O

Obio Technology Shanghai Corp Ltd
SSE:688238

Watchlist Manager
Obio Technology Shanghai Corp Ltd
SSE:688238
Watchlist
Price: 5.48 CNY -6.16% Market Closed
Market Cap: 3.5B CNY
Have any thoughts about
Obio Technology Shanghai Corp Ltd?
Write Note

Obio Technology Shanghai Corp Ltd
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Obio Technology Shanghai Corp Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
O
Obio Technology Shanghai Corp Ltd
SSE:688238
Inventory
ÂĄ80.8m
CAGR 3-Years
54%
CAGR 5-Years
75%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Inventory
ÂĄ5.2B
CAGR 3-Years
13%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Inventory
ÂĄ1.2B
CAGR 3-Years
39%
CAGR 5-Years
53%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Inventory
ÂĄ2B
CAGR 3-Years
5%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Inventory
ÂĄ22.1m
CAGR 3-Years
56%
CAGR 5-Years
86%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Inventory
ÂĄ46.8m
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Obio Technology Shanghai Corp Ltd
Glance View

Market Cap
3.5B CNY
Industry
Life Sciences Tools & Services

Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.

Intrinsic Value
4.5 CNY
Overvaluation 18%
Intrinsic Value
Price
O

See Also

What is Obio Technology Shanghai Corp Ltd's Inventory?
Inventory
80.8m CNY

Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Inventory amounts to 80.8m CNY.

What is Obio Technology Shanghai Corp Ltd's Inventory growth rate?
Inventory CAGR 5Y
75%

Over the last year, the Inventory growth was 23%. The average annual Inventory growth rates for Obio Technology Shanghai Corp Ltd have been 54% over the past three years , 75% over the past five years .

Back to Top